Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Htg Molecular Dia (HTGM)

Htg Molecular Dia (HTGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,063
  • Shares Outstanding, K 2,214
  • Annual Sales, $ 6,370 K
  • Annual Income, $ -21,590 K
  • 60-Month Beta 0.99
  • Price/Sales 0.21
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade HTGM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -13.68
  • Most Recent Earnings $-2.28 on 05/10/23
  • Next Earnings Date 08/10/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -1.84
  • Number of Estimates 1
  • High Estimate -1.84
  • Low Estimate -1.84
  • Prior Year -6.48
  • Growth Rate Est. (year over year) +71.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4621 +3.87%
on 06/14/23
3.2399 -85.18%
on 05/22/23
-2.2100 (-82.16%)
since 05/12/23
3-Month
0.4621 +3.87%
on 06/14/23
4.7700 -89.94%
on 04/18/23
-2.7500 (-85.14%)
since 03/14/23
52-Week
0.4621 +3.87%
on 06/14/23
24.9600 -98.08%
on 07/18/22
-5.1000 (-91.40%)
since 06/14/22

Most Recent Stories

More News
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of -25% and 1%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

KRMD : 2.20 (+0.46%)
HTGM : 0.4800 (-20.00%)
LivaNova (LIVN) Beats Q1 Earnings and Revenue Estimates

LivaNova (LIVN) delivered earnings and revenue surprises of 4.88% and 8.59%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

LIVN : 59.60 (+0.37%)
HTGM : 0.4800 (-20.00%)
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of 68% and 19.72%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TMDX : 140.29 (+2.01%)
HTGM : 0.4800 (-20.00%)
Molecular Templates Inc. (MTEM) Reports Q4 Loss, Lags Revenue Estimates

Molecular Templates Inc. (MTEM) delivered earnings and revenue surprises of -56% and 63.99%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

MTEM : 1.2500 (-5.30%)
HTGM : 0.4800 (-20.00%)
Three Small-Cap Biotech Stocks to Consider Now

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 

HARP : 23.01 (+0.09%)
HTGM : 0.4800 (-20.00%)
ABEO : 4.06 (-2.64%)
HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Misses Revenue Estimates

HTG Molecular Diagnostics, Inc. (HTGM) delivered earnings and revenue surprises of 21.15% and 44.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

HTGM : 0.4800 (-20.00%)
AFMD : 4.19 (-11.04%)
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates

Neuronetics (STIM) delivered earnings and revenue surprises of 36.36% and 11.55%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STIM : 2.18 (-5.22%)
HTGM : 0.4800 (-20.00%)
ReWalk Robotics (RWLK) Reports Q3 Loss, Lags Revenue Estimates

ReWalk (RWLK) delivered earnings and revenue surprises of -50% and 51.32%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

RWLK : 1.0501 (+6.07%)
HTGM : 0.4800 (-20.00%)
HTG Molecular Diagnostics, Inc. (HTGM) Moves to Buy: Rationale Behind the Upgrade

HTG Molecular Diagnostics, Inc. (HTGM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

HTGM : 0.4800 (-20.00%)
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of -9.52% and 4.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TMCI : 5.16 (+2.38%)
HTGM : 0.4800 (-20.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Its products include...

See More

Key Turning Points

3rd Resistance Point 0.7204
2nd Resistance Point 0.6651
1st Resistance Point 0.5726
Last Price 0.4800
1st Support Level 0.4248
2nd Support Level 0.3695
3rd Support Level 0.2770

See More

52-Week High 24.9600
Fibonacci 61.8% 15.6018
Fibonacci 50% 12.7110
Fibonacci 38.2% 9.8203
Last Price 0.4800
52-Week Low 0.4621

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar